Isolation and characterization of NMSO3-resistant mutants of respiratory syncytial virus

Antiviral Res. 2004 Mar;61(3):165-71. doi: 10.1016/j.antiviral.2003.09.008.

Abstract

We obtained two mutant strains of respiratory syncytial virus (RSV) which showed resistance against NMSO3 after 15 and 33 passages, respectively, in HEp-2 cells in the presence of 6.8 microM of NMSO3. The EC50 values of NMSO3 for the resistant virus strains were 0.48 and 0.93 microM, that is 4.8-9.3 times higher than that of the parent strain (EC50 = 0.1 microM). The most resistant strain also showed resistance against heparin but was sensitive to dextran sulfate and a polyoxotungstate, PM-523. In order to determine whether the acquisition of resistance to NMSO3 was the result of the accumulation of genetic changes of virus, we sequenced the G- and F-protein genes. In comparison with the standard type of RSV strains, we identified changes of 10 amino acids in the G protein including those at the central conserved segment. However, we did not observe any particular changes in the amino acid sequence of the F-protein of the resistant strains. From these results, we conclude that NMSO3 inhibits the G-protein interaction to the receptor. The mutations in the G-protein may result in the observed phenotypic resistance of RSV towards NMSO3.

MeSH terms

  • Antiviral Agents / pharmacology*
  • Cell Line, Tumor
  • Conserved Sequence
  • DNA Mutational Analysis
  • Dextran Sulfate / pharmacology
  • Drug Resistance, Viral / genetics*
  • Heparin / pharmacology
  • Humans
  • Lipids / pharmacology*
  • Mutation, Missense
  • N-Acetylneuraminic Acid / analogs & derivatives*
  • N-Acetylneuraminic Acid / pharmacology*
  • Nucleic Acid Amplification Techniques
  • RNA, Viral / isolation & purification
  • Respiratory Syncytial Viruses / drug effects*
  • Respiratory Syncytial Viruses / genetics*
  • Respiratory Syncytial Viruses / growth & development
  • Respiratory Syncytial Viruses / isolation & purification
  • Viral Proteins / genetics

Substances

  • (2,2-bis(docosyloxymethyl)propyl-5-acetamido-3,5-dideoxy-4,7,8,9-tetra-O-(sodium oxysulfonyl)glycero-alpha-galacto-2-nonulopyranosid)onate
  • Antiviral Agents
  • Lipids
  • RNA, Viral
  • Viral Proteins
  • Heparin
  • Dextran Sulfate
  • N-Acetylneuraminic Acid